You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CPI-200

Showing 1 - 25 of 3,450
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor Trial in Grand Rapids (CPI-200)

Completed
  • Advanced Solid Tumor
  • CPI-200
  • Grand Rapids, Michigan
    South Texas Accelerated Research Therapeutics (START Midwest)
Feb 22, 2022

Recurrent Ovarian Cancer Trial in Pittsburgh (CPI-0209, carboplatin)

Not yet recruiting
  • Recurrent Ovarian Cancer
  • Pittsburgh, Pennsylvania
    Magee-Womens Research Institute / UPMC Magee Womens Hospital
Jul 3, 2023

Mycosis Fungoides, Sezary Syndrome, Mycosis Fungoides/Sezary Syndrome Trial in Saint Louis (Tulmimetostat)

Not yet recruiting
  • Mycosis Fungoides
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 13, 2023

Covid-19 Trial in Worldwide (CPI-006 2 mg/kg + SOC, CPI-006 1 mg/kg + SOC, Placebo + SOC)

Terminated
Has Results
  • Covid-19
  • CPI-006 2 mg/kg + SOC
  • +2 more
  • Chula Vista, California
  • +90 more
Sep 7, 2022

Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer Trial in United States (NT-I7,

Recruiting
  • Any Advanced Solid Tumors
  • +6 more
  • Tampa, Florida
  • +7 more
Jul 13, 2022

Understanding immunE-related toXicities by multifACeT Profiling

Recruiting
  • Oncology
    • Chelsea, London, United Kingdom
      Royal Marsden NHS Foundation Trust
    Apr 21, 2022

    Carcinoma, Squamous Cell of Head and Neck, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in United

    Terminated
    • Carcinoma, Squamous Cell of Head and Neck
    • +3 more
    • Coral Gables, Florida
    • +4 more
    Mar 1, 2022

    Non-Small Cell Lung Carcinoma (NSCLC), Colorectal Cancer (CRC), Other Solid Tumors Trial in Israel (Selinexor 100 mg, Docetaxel,

    Recruiting
    • Non-Small Cell Lung Carcinoma (NSCLC)
    • +2 more
    • Selinexor 100 mg
    • +6 more
    • Ashdod, Israel
    • +10 more
    Jan 30, 2023

    Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Worldwide (Pelabresib, Ruxolitinib, Placebo)

    Recruiting
    • Myelofibrosis
    • +3 more
    • Birmingham, Alabama
    • +148 more
    Oct 10, 2022

    MDS, Progressive Disease Trial in Buffalo, Winston-Salem (CPI-613, Hydroxychloroquine)

    Withdrawn
    • Myelodysplastic Syndromes
    • Progressive Disease
    • Buffalo, New York
    • +1 more
    Apr 8, 2021

    Metastatic Solid Tumors, NSCLC, Melanoma Trial in United States (INBRX-105 - PDL1x41BB antibody, Pembrolizumab)

    Recruiting
    • Metastatic Solid Tumors
    • +7 more
    • Scottsdale, Arizona
    • +12 more
    Jan 26, 2023

    Squamous Cell Carcinoma of the Head and Neck Trial in United States (SNS-301, Pembrolizumab)

    Terminated
    Has Results
    • Squamous Cell Carcinoma of the Head and Neck
    • San Francisco, California
    • +9 more
    Dec 6, 2022

    Locally Advanced or Metastatic Renal Cell Carcinoma Trial in Worldwide (Cabozantinib)

    Active, not recruiting
    • Locally Advanced or Metastatic Renal Cell Carcinoma
    • Salzburg, Austria
    • +39 more
    Jan 18, 2023

    Advanced Tumors Trial in Grand Rapids, Cleveland, San Antonio (CPI-100, Capecitabine)

    Completed
    • Advanced Tumors
    • Grand Rapids, Michigan
    • +2 more
    Jul 19, 2022

    Intracerebral Hemorrhage Trial in Gent, Mons, Kortrijk (Ir-CPI)

    Recruiting
    • Intracerebral Hemorrhage
    • Gent, East Flanders, Belgium
    • +2 more
    Aug 2, 2023

    Lymphoma, Leukemia Trial in United States (CPI-613)

    Recruiting
    • Lymphoma
    • Leukemia
    • Duarte, California
    • +9 more
    Nov 28, 2022

    B-Cell Lymphoma Trial in United States (CPI-1205)

    Completed
    • B-Cell Lymphoma
    • Lafayette, Indiana
    • +5 more
    May 16, 2022

    Advanced Tumors Trial in United States (CPI-300)

    Recruiting
    • Advanced Tumors
    • Scottsdale, Arizona
    • +3 more
    Jul 19, 2022

    Asthma, Aspirin-Induced Trial in United States (Ifetroban Oral Capsule, Placebo Oral Capsule)

    Active, not recruiting
    • Asthma, Aspirin-Induced
    • Ifetroban Oral Capsule
    • Placebo Oral Capsule
    • Tucson, Arizona
    • +15 more
    Nov 16, 2022

    Advanced Malignancies, Solid Tumor, Hematological Malignancy Trial in Canton, Gettysburg, West Valley City (Pelabresib)

    Recruiting
    • Advanced Malignancies
    • +2 more
    • Canton, Ohio
    • +6 more
    Jan 30, 2023

    Colorectal Tumors Malignant Trial in Beijing (Fecal microbiota transplantation plus Sintilimab and Fruquintinib)

    Recruiting
    • Colorectal Neoplasms Malignant
    • Fecal microbiota transplantation plus Sintilimab and Fruquintinib
    • Beijing, China
      National Cancer Center/Cancer Hospital, Chinese Academy of Medic
    Aug 21, 2022

    Advanced Solid Tumors Trial in Grand Rapids, Houston, San Antonio (CPI-1205, ipilimumab)

    Completed
    • Advanced Solid Tumors
    • Grand Rapids, Michigan
    • +2 more
    May 16, 2022

    T-cell Lymphoma Trial in Worldwide (CPI-818)

    Recruiting
    • T-cell Lymphoma
    • Palo Alto, California
    • +21 more
    Jun 20, 2022

    NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

    Active, not recruiting
    • Non-Small Cell Lung Cancer
    • +12 more
    • Tucson, Arizona
    • +26 more
    Aug 1, 2022

    Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, Granulocytic Sarcoma Trial in Winston-Salem (drug,

    Not yet recruiting
    • Acute Myeloid Leukemia, in Relapse
    • +2 more
    • CPI 613
    • +3 more
    • Winston-Salem, North Carolina
      Wake Forest Baptist Comprehensive Cancer Center
    May 10, 2023